cas 123387-52-0|| where to buy tert-Butyl azepane-1-carboxylate

Nom du produit:tert-Butyl azepane-1-carboxylate

IUPAC Name:tert-butyl azepane-1-carboxylate

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM284811-1g	in stock	ŵƿ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 123387-52-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:123387-52-0; Formule moléculaire:C11H21NO2; Point de fusion:-; Code SMILES:O=C(N1CCCCCC1)OC(C)(C)C; Densité:

: Numéro de catalogue:CM284811; Poids moléculaire:199.29; Point d'ébullition:; N° Mdl:MFCD18252672; Stockage:

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.

: Taplucainium chloride; Nocion Therapeutics presents data on preclinical and clinical development of Taplucainium, a novel, charged sodium channel blocker, as a potential treatment for chronic cough at the 13th London International Cough Symposium.
Taplucainium is a proprietary molecule in the novel class of charged sodium channel blockers that allows for specific silencing of activated/inflamed nociceptors while having minimal local off-target effects or systemic exposure. Unlike other investigative cough therapies, such as P2X3-antagonists, TRPA1-antagonists and TRPM8-agonists, which target a specific large pore channel, taplucainium works downstream by selectively targeting the sodium channels in activated nociceptors which are the target of these large pore channels.